TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas

• Published in: Modern pathology Vol. 34; no. 6; pp. 1133 - 1142
• Main Authors: Brown, Noah A., Plouffe, Komal R., Yilmaz, Osman, Weindorf, Steven C., Betz, Bryan L., Carey, Thomas E., Seethala, Raja R., McHugh, Jonathan B., Tomlins, Scott A., Udager, Aaron M.
• Format: Journal Article
• Language: English
• Published: New York Elsevier Inc 01.06.2021; Nature Publishing Group US; Elsevier Limited
• Subjects: 45; 45/23; 631/67/1536; 631/67/69; Cell Transformation, Neoplastic - genetics; Cyclin-Dependent Kinase Inhibitor p16 - genetics; Disease Progression; DNA Copy Number Variations; DNA sequencing; Epidermal growth factor receptors; Fibroblast growth factor receptor 1; Genomes; Human papillomavirus; Humans; Infections; Laboratory Medicine; Medicine; Medicine & Public Health; Molecular modelling; Mutation; Myc protein; p53 Protein; Papilloma; Papilloma - genetics; Papilloma - pathology; Paranasal Sinus Neoplasms - genetics; Paranasal Sinus Neoplasms - pathology; Pathology; Phenotypes; Squamous cell carcinoma; Tumor Suppressor Protein p53 - genetics; Tumors
• ISSN: 0893-3952; 1530-0285
• DOI: 10.1038/s41379-020-00716-3

Sinonasal papillomas are benign epithelial tumors of the sinonasal tract that are associated with a synchronous or metachronous sinonasal carcinoma in a subset of cases. Our group recently identified mutually exclusive EGFR mutations and human papillomavirus (HPV) infection in inverted sinonasal papillomas and frequent KRAS mutations in oncocytic sinonasal papillomas. We also demonstrated concordant mutational and HPV infection status in sinonasal papilloma-associated sinonasal carcinomas, confirming a clonal relationship between these tumors. Despite our emerging understanding of the oncogenic mechanisms driving formation of sinonasal papillomas, little is currently known about the molecular mechanisms of malignant progression to sinonasal carcinoma. In the present study, we utilized targeted next-generation DNA sequencing to characterize the molecular landscape of a large cohort of sinonasal papilloma-associated sinonasal carcinomas. As expected, EGFR or KRAS mutations were present in the vast majority of tumors. In addition, highly recurrent TP53 mutations, CDKN2A mutations, and/or CDKN2A copy-number losses were detected; overall, nearly all tumors (n = 28/29; 96.6%) harbored at least one TP53 or CDKN2A alteration. TERT copy-number gains also occurred frequently (27.6%); however, no TERT promoter mutations were identified. Other recurrent molecular alterations included NFE2L2 and PIK3CA mutations and SOX2, CCND1, MYC, FGFR1, and EGFR copy-number gains. Importantly, TP53 mutations and CDKN2A alterations were not detected in matched sinonasal papillomas, suggesting that these molecular events are associated with malignant transformation. Compared to aerodigestive tract squamous cell carcinomas from The Cancer Genome Atlas (TCGA) project, sinonasal papilloma-associated sinonasal carcinomas have a distinct molecular phenotype, including more frequent EGFR, KRAS, and CDKN2A mutations, TERT copy-number gains, and low-risk human papillomavirus (HPV) infection. These findings shed light on the molecular mechanisms of malignant progression of sinonasal papillomas and may have important diagnostic and therapeutic implications for patients with advanced sinonasal cancer.